Antibodies, Monoclonal
Showing 1 - 25 of 7,565
Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)
Completed
- Clostridium Infection
- Collection of peripheral blood mononuclear cells
-
Paris, FranceMaladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
Oct 3, 2022
Isolation of Human Recombinant Therapeutic Monoclonal
Recruiting
- Pseudomonas Aeruginosa
- Multi-antibiotic Resistance
- Isolation of anti-Pseudomonas antibodies from type B lymphocytes
-
Grenoble, FranceChu Grenoble Alpes
May 6, 2022
A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies
Recruiting
- Immunocompromised Patients
- Data collection
-
Paris, Ile De France, FranceAssistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
Jul 5, 2022
Headache, Migraine Trial in Chicago, Naperville (Ubrogepant 50 MG [Ubrelvy], Ubrogepant 100 MG [Ubrelvy])
Not yet recruiting
- Headache, Migraine
- Ubrogepant 50 MG [Ubrelvy]
- Ubrogepant 100 MG [Ubrelvy]
-
Chicago, Illinois
- +1 more
Aug 14, 2022
Against BK Virus Infection Based on Monoclonal Antibodies
Not yet recruiting
- BK Virus Infection
-
Strasbourg, FranceService de Virologie - CHU Strasbourg - France
Feb 21, 2022
Monoclonal Antibodies (Sotrovimab )
Recruiting
- COVID-19 Respiratory Infection
-
Dubai, United Arab EmiratesEmirats Health Service
Dec 13, 2021
Allergic Rhinitis, Conjunctivitis Trial (REGN5713, REGN5714, REGN5715)
Not yet recruiting
- Allergic Rhinitis
- Conjunctivitis
- REGN5713
- +3 more
- (no location specified)
Jun 20, 2022
COVID-19 Trial in Hong Kong (BRII-196 and BRII-198, Placebo)
Withdrawn
- COVID-19
- BRII-196 and BRII-198
- Placebo
-
Hong Kong, ChinaInvestigative Site 1
Mar 1, 2022
SURvival of SEzary Syndrome Over 1998-2020 Period and Its
Not yet recruiting
- Sezary Syndrome
- Cutaneous T Lymphoma
- Standard of care
-
Paris, FranceHôpital Saint-Louis, Service de Dermatologie
Jan 24, 2022
Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)
Recruiting
- Infusion Reaction
- Monoclonal Antibody
- Montelukast 10 Mg Oral Tablet
-
Clovis, CaliforniaCommunity Cancer Institute
Nov 8, 2021
COVID-19 Trial in Beijing (BRII-196 and BRII-198, Placebo)
Completed
- COVID-19
- BRII-196 and BRII-198
- Placebo
-
Beijing, Beijing, ChinaInvestigative Site
Mar 1, 2022
Acquiring Convalescent Specimens for COVID-19 Antibodies
Completed
- COVID-19
- +2 more
- Blood draw
-
New York, New YorkColumbia University Irving Medical Center/NYP
Jul 18, 2022
Covid19 Trial in Edinburg, Rio Grande City (BAMLANIVIMAB, CASIRIVIMAB, IMDEVIMAB)
Recruiting
- Covid19
- BAMLANIVIMAB
- +2 more
-
Edinburg, Texas
- +2 more
Mar 14, 2022
Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)
Recruiting
- Non Small Cell Lung Cancer
- +6 more
- FT536
- +10 more
-
Scottsdale, Arizona
- +4 more
Dec 27, 2022
COVID-19 : Neutralizing Human Monoclonal Antibodies Against
Completed
- COVID
- Blood sample
-
Lyon, FranceHôpital de la Croix-Rousse
Jun 17, 2021
Consistency of PD-L1 Detecting Method Between E1L3N and 22C3
Completed
- Non Small Cell Lung Cancer
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Nov 20, 2021
TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use
Recruiting
- COVID-19
- casirivimab with imdevimab
- +2 more
-
Amsterdam, Noord Holland, Netherlands
- +3 more
Jan 13, 2022
COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,
Suspended
- COVID-19 Infection
- +2 more
- Questionnaire Administration
- Sotrovimab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 24, 2023
COVID-19 Trial in China (BRII-196 and BRII-198, Placebo)
Completed
- COVID-19
- BRII-196 and BRII-198
- Placebo
-
Beijing, Beijing, China
- +5 more
Mar 1, 2022
Breast Cancer Trial in Besançon (additional blood sample)
Completed
- Breast Cancer
- additional blood sample
-
Besançon, FranceCentre Hospitalier Régional Universitaire
Apr 15, 2021